NLM Logo

ofatumumab MeSH Supplementary Concept Data 2022


MeSH Supplementary
ofatumumab
Unique ID
C527517
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C527517
Entry Term(s)
GSK-1841157
GSKI841157
HUMAX-CD20 2F2
HUMAX-CD20, 2F2
HUMAX-CD20-2F2
arzerra
kesimpta
Pharm Action
Antineoplastic Agents
Registry Number
M95KG522R0
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
382
Note
an anti-CD20 MAb used as an antineoplastic agent; in phase 1-2 clinical trials
Source
Blood 2008 Feb 1;111(3):1094-100
Indexing Information
Antigens, CD20
Date of Entry
2008/03/24
Revision Date
2021/08/18
ofatumumab Preferred
kesimpta Narrower
HUMAX-CD20 2F2 Narrower
GSKI841157 Narrower
arzerra Narrower
page delivered in 0.004s